TipRanks
Sanuwave Health (SNWV)
NASDAQ:SNWV
US Market
SNWV
Sanuwave Health
RESEARCH TOOLSreports
Want to see SNWV full AI Analyst Report?

Sanuwave Health (SNWV) Ratios

56 Followers

Sanuwave Health Ratios

SNWV's free cash flow for Q2 2026 was $0.76. For the 2026 fiscal year, SNWV's free cash flow was decreased by $ and operating cash flow was $-0.02. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Mar 23
Liquidity Ratios
Current Ratio
 1.28 1.38 0.43 0.15 0.11
Quick Ratio
 0.89 1.05 0.34 0.11 0.10
Cash Ratio
 0.52 0.67 0.24 0.03 0.02
Solvency Ratio
 0.46 0.37 -0.71 -0.38 -0.15
Operating Cash Flow Ratio
 0.29 0.22 0.06 -0.07 -0.29
Short-Term Operating Cash Flow Coverage
 0.93 0.69 0.10 -0.15 -0.45
Net Current Asset Value
$ -10.62M$ -11.10M$ -24.44M$ -55.81M$ -54.26M
Leverage Ratios
Debt-to-Assets Ratio
 0.57 0.62 0.85 1.36 1.96
Debt-to-Equity Ratio
 7.43 14.19 -2.00 -0.71 -0.95
Debt-to-Capital Ratio
 0.88 0.93 2.00 -2.39 -19.16
Long-Term Debt-to-Capital Ratio
 0.83 0.91 0.00 0.00 0.00
Financial Leverage Ratio
 13.13 23.07 -2.37 -0.52 -0.48
Debt Service Coverage Ratio
 2.09 1.63 -0.43 -0.20 0.09
Interest Coverage Ratio
 0.19 0.79 0.40 -0.03 -0.63
Debt to Market Cap
 0.47 0.09 0.25 2.91 3.08
Interest Debt Per Share
 2.82 3.41 8.77 21.77 36.24
Net Debt to EBITDA
 0.59 0.57 -0.92 -3.13 7.89
Profitability Margins
Gross Profit Margin
75.20%77.11%75.23%70.41%74.13%
EBIT Margin
40.97%41.19%-54.26%-49.91%22.94%
EBITDA Margin
43.91%44.10%-50.75%-44.87%28.63%
Operating Profit Margin
1.54%11.23%16.60%-2.65%-53.47%
Pretax Profit Margin
32.81%27.01%-96.05%-126.50%-61.47%
Net Profit Margin
32.60%26.82%-96.13%-126.52%-61.48%
Continuous Operations Profit Margin
32.60%26.82%-96.13%-126.52%-61.48%
Net Income Per EBT
99.36%99.28%100.09%100.02%100.02%
EBT Per EBIT
2124.63%240.63%-578.64%4778.33%114.96%
Return on Assets (ROA)
39.10%31.63%-104.16%-115.13%-51.79%
Return on Equity (ROE)
1728.10%729.65%246.69%59.77%25.10%
Return on Capital Employed (ROCE)
3.68%25.36%-44.31%1.28%22.19%
Return on Invested Capital (ROIC)
2.80%19.41%41.42%4.36%496.23%
Return on Tangible Assets
54.10%43.66%-164.00%-240.69%-137.68%
Earnings Yield
36.02%4.62%-30.56%-250.32%-82.16%
Efficiency Ratios
Receivables Turnover
 7.57 8.12 9.80 6.16 4.16
Payables Turnover
 3.29 3.13 2.17 1.06 0.98
Inventory Turnover
 1.54 1.70 1.95 2.05 4.99
Fixed Asset Turnover
 13.69 18.65 44.58 21.75 19.56
Asset Turnover
 1.20 1.18 1.08 0.91 0.84
Working Capital Turnover Ratio
 8.22 -5.13 -0.83 -0.38 -0.32
Cash Conversion Cycle
 174.33 143.22 56.24 -107.26 -209.83
Days of Sales Outstanding
 48.23 44.93 37.23 59.30 87.84
Days of Inventory Outstanding
 236.99 214.83 187.33 178.48 73.15
Days of Payables Outstanding
 110.88 116.54 168.32 345.04 370.82
Operating Cycle
 285.22 259.76 224.56 237.78 160.99
Cash Flow Ratios
Operating Cash Flow Per Share
 0.61 0.45 0.55 -2.14 -11.72
Free Cash Flow Per Share
 0.72 0.23 0.44 -2.14 -11.02
CapEx Per Share
 0.11 0.23 0.11 0.00 0.70
Free Cash Flow to Operating Cash Flow
 1.18 0.50 0.80 1.00 0.94
Dividend Paid and CapEx Coverage Ratio
 5.42 2.00 5.01 0.00 -16.80
Capital Expenditure Coverage Ratio
 5.42 2.00 5.01 0.00 -16.80
Operating Cash Flow Coverage Ratio
 0.25 0.17 0.10 -0.15 -0.44
Operating Cash Flow to Sales Ratio
 0.12 0.09 0.08 -0.22 -1.03
Free Cash Flow Yield
15.57%0.76%1.91%-44.02%-128.89%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 2.85 21.62 -3.27 -0.40 -1.22
Price-to-Sales (P/S) Ratio
 0.93 5.80 3.15 0.51 0.75
Price-to-Book (P/B) Ratio
 14.69 157.84 -8.07 -0.24 -0.31
Price-to-Free Cash Flow (P/FCF) Ratio
 6.62 132.13 52.24 -2.27 -0.78
Price-to-Operating Cash Flow Ratio
 7.84 65.93 41.81 -2.27 -0.73
Price-to-Earnings Growth (PEG) Ratio
 <0.01 -0.18 0.08 >-0.01 0.02
Price-to-Fair Value
 14.69 157.84 -8.07 -0.24 -0.31
Enterprise Value Multiple
 2.71 13.72 -7.12 -4.26 10.51
Enterprise Value
 51.06M 266.55M 117.91M 38.97M 50.35M
EV to EBITDA
 2.65 13.72 -7.12 -4.26 10.51
EV to Sales
 1.16 6.05 3.61 1.91 3.01
EV to Free Cash Flow
 8.25 137.82 60.00 -8.59 -3.12
EV to Operating Cash Flow
 9.78 68.77 48.03 -8.59 -2.93
Tangible Book Value Per Share
 -0.86 -1.01 -5.31 -25.92 -36.45
Shareholders’ Equity Per Share
 0.32 0.19 -2.85 -20.40 -27.99
Tax and Other Ratios
Effective Tax Rate
 <0.01 <0.01 >-0.01 >-0.01 >-0.01
Revenue Per Share
 5.10 5.14 7.31 9.64 11.43
Net Income Per Share
 1.66 1.38 -7.03 -12.19 -7.02
Tax Burden
 0.99 0.99 1.00 1.00 1.00
Interest Burden
 0.80 0.66 1.77 2.53 -2.68
Research & Development to Revenue
 0.05 0.03 0.02 0.03 0.03
SG&A to Revenue
 0.67 0.61 0.54 0.43 0.75
Stock-Based Compensation to Revenue
 -0.05 0.00 0.05 0.00 0.00
Income Quality
 2.09 0.33 -0.08 0.18 1.67
Currency in USD